| Adjuvant Therapy Receipt (n = 164)a | Completion of Prescribed Adjuvant Chemotherapy (n = 81)b | ||
---|---|---|---|---|
Data Variable | Univariable | Multivariable | Univariable | Multivariable |
PrRa (95% CI) | PrR (95% CI) | PrR (95% CI) | PrR (95% CI) | |
Agea | ||||
  < 50 years | REF | REF | REF | REF |
  ≥ 50 years | 1.0 (0.7–1.5) | 1.0 (0.7–1.5) | 0.8 (0.5–1.5) | 0.9 (0.5–1.6) |
Referralb | 0.9 (0.6–1.3) | 0.9 (0.6–1.3) | 0.9 (0.5–1.6) | 0.8 (0.5–1.6) |
Mwanza Cityc | 1.0 (0.7–1.8) | 1.0 (0.6–1.7) | 1.0 (0.5–2.1) | 1.1 (0.6–2.1) |
Insurance | 1.5 (1.0–2.2) | 1.3 (0.9–2.0) | 1.8 (1.0–3.2) | 1.7 (0.9–3.1) |
Histopathological Diagnosisd | 3.0 (1.7–5.4) | 3.0 (1.7–5.4) | 1.1 (0.4–2.7) | 1.4 (0.5–3.5) |
Clinically Positive Nodese | 1.1 (0.6–1.9) | 1.0 (0.6–1.9) | 1.6 (0.8–3.1) | 1.4 (0.7–2.9) |
Suspected Distant Metastasesf | 1.1 (0.7–1.8) | 1.2 (0.7–2.2) | 1.8 (1.0–3.4) | 1.5 (0.7–3.3) |